MEDBOX | Toolbox Access & Strategy

NEW

Bundesgesundheitsministerium (2021) CC

15. Dezember 2020

Tags: Impfung, COVID-19, SARS-CoV-2, Deutschland, Strategie, Risikogruppen,

Source: https://www.bundesgesundheitsministerium

Ritchie, H.; et al. One World Data (2021) CC

In our Data Explorer you can see our COVID-19 vaccination data — you can also visualize the latest data on confirmed cases, deaths, and testing.

Tags: dashboard, COVID-19, Vaccination,

Source: https://ourworldindata.org/covid-vaccina

Pan American Health Organisation PAHO (2021) C_WHO

Tags: dashboard, COVID-19, Vaccination,

Source: https://ais.paho.org/imm/IM_DosisAdmin-V

WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply

World Health Organization WHO (2021) C_WHO

an approach to inform planning and subsequent recommendations based on epidemiological setting and vaccine supply scenarios, first issued 20 October 2020, latest update 16 July 2021 Given the urgency and wide-ranging effects of the COVID-19 pandemic, SAGE has developed an approach to help inform deliberation around the range of recommendations that may be appropriate under different epidemiologic and vaccine supply conditions. To assist in developing recommendations for use of vaccines against COVID-19, SAGE proposes a Roadmap for Prioritizing Uses of COVID-19 Vaccines that considers priority populations for vaccination based on epidemiologic setting and vaccine supply scenarios

Tags: roadmap, vaccine, Allocation, SARS-CoV-2, Supply, equitable access, priorization,

Source: https://apps.who.int/iris/bitstream/hand

Statement on Covishield and the European Union (EU) Digital COVID Certificate “Green Pass”

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

Tags: certificate, vaccine certificate, COVID-19, travellers,

Source: https://africacdc.org/download/statement

Déclaration relative au vaccin Covishield ainsi que sur le passeport numérique de l’Union européenne (UE) sur le COVID intitulé “Pass vert”

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

Tags: certificate, vaccine certificate, COVID-19, travellers,

Source: https://africacdc.org/download/statement

Orientação para a elaboração de um plano nacional de operacionalização da vacinação contra a COVID-19. Orientação Provisória. 1 de junho de 2021

World Health Organization WHO (2021) C_WHO

Este documento de orientação para elaboração de um plano nacional de operacionalização e vacinação (NDVP) apresenta um esquema que auxilia os países a: desenvolver e atualizar o respectivo NDVP para a introdução de vacinas contra a COVID-19; elaborar estratégias para a operacionalização e o monitoramento da(s) vacina(s) contra a COVID-19 no país; garantir que o plano e o financiamento relacionado estejam bem alinhados a outros planos nacionais de suporte à recuperação e resposta à COVID-19, e que a implementação esteja totalmente integrada nos mecanismos nacionais de governança.Este documento de orientação baseia-se em documentos de orientação já existentes sobre a introdução de novas vacinas, elaborados anteriormente pela OMS mediante consulta com especialistas no assunto, e é embasado por materiais recentes sobre vacinas contra a COVID-19, endossados pelo SAGE OM

Tags: COVID-19, Vaccination, strategy, national action plan, National Vaccination Plan, NDVP,

Source: https://iris.paho.org/bitstream/handle/1

WHO supporting South African consortium to establish first COVID mRNA vaccine technology transfer hub

World Health Organization WHO (2021) CC

21 June 2021

Tags: skill transfer, mRNA, training hubs, Vaccine production, COVID-19, South Africa,

Source: https://www.who.int/news/item/21-06-2021

G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021

World Health Organization WHO; CEPI, GAVI, UNICEF (2021) C_WHO

13 June 2021

Tags: vaccine, donations, COVID-19, G7, Access, covax,

Source: https://www.who.int/news/item/13-06-2021

Vygen-Bonnet S, Koch J, Bogdan C, et al. (2021) C1

Epidemiologisches Bulletin 19 | 2021 12.Mai 2021. Auf Basis der derzeit verfügbaren, allerdings noch begrenzten Evidenz und unter Berücksichtigung der gegenwärtigen pandemischen Lage empfiehlt die STIKO, Vaxzevria und COVID-19 Vaccine Janssen für Personen im Alter ≥60 Jahren zu verwenden. Der Einsatz von Vaxzevria für eine 1. oder 2. Impfstoffdosis und der COVID-19 Vaccine Janssen als einmalige Impfung unterhalb dieser Altersgrenze bleibt indes nach ärztlicher Aufklärung und bei individueller Risikoakzeptanz durch die impfwillige Person möglich

Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson,

Source: https://www.rki.de/DE/Content/Infekt/Epi

	Verordnung um Anspruch auf Schutzimpfunggegen das Coronavirus SARS-CoV-2 (Coronavirus-Impfverordnung–CoronaImpfV) NEW Bundesgesundheitsministerium (2021) CC View PDF(12) Download (4) Add to my MEDBOX 15. Dezember 2020 Tags: Impfung, COVID-19, SARS-CoV-2, Deutschland, Strategie, Risikogruppen, Source: https://www.bundesgesundheitsministerium
	Coronavirus (COVID-19) Vaccinations Ritchie, H.; et al. One World Data (2021) CC Open external link (117) Add to my MEDBOX In our Data Explorer you can see our COVID-19 vaccination data — you can also visualize the latest data on confirmed cases, deaths, and testing. Tags: dashboard, COVID-19, Vaccination, Source: https://ourworldindata.org/covid-vaccina
	Covid-19 Vaccinations in the Americas Pan American Health Organisation PAHO (2021) C_WHO Open external link (5) Add to my MEDBOX Tags: dashboard, COVID-19, Vaccination, Source: https://ais.paho.org/imm/IM_DosisAdmin-V
	WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply World Health Organization WHO (2021) C_WHO View PDF(1) Download (0) Add to my MEDBOX an approach to inform planning and subsequent recommendations based on epidemiological setting and vaccine supply scenarios, first issued 20 October 2020, latest update 16 July 2021 Given the urgency and wide-ranging effects of the COVID-19 pandemic, SAGE has developed an approach to help inform deliberation around the range of recommendations that may be appropriate under different epidemiologic and vaccine supply conditions. To assist in developing recommendations for use of vaccines against COVID-19, SAGE proposes a Roadmap for Prioritizing Uses of COVID-19 Vaccines that considers priority populations for vaccination based on epidemiologic setting and vaccine supply scenarios Tags: roadmap, vaccine, Allocation, SARS-CoV-2, Supply, equitable access, priorization, Source: https://apps.who.int/iris/bitstream/hand
	Statement on Covishield and the European Union (EU) Digital COVID Certificate “Green Pass” African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC View PDF(2) Download (1) Add to my MEDBOX Tags: certificate, vaccine certificate, COVID-19, travellers, Source: https://africacdc.org/download/statement
	Déclaration relative au vaccin Covishield ainsi que sur le passeport numérique de l’Union européenne (UE) sur le COVID intitulé “Pass vert” African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC View PDF(1) Download (1) Add to my MEDBOX Tags: certificate, vaccine certificate, COVID-19, travellers, Source: https://africacdc.org/download/statement
	Orientação para a elaboração de um plano nacional de operacionalização da vacinação contra a COVID-19. Orientação Provisória. 1 de junho de 2021 World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Este documento de orientação para elaboração de um plano nacional de operacionalização e vacinação (NDVP) apresenta um esquema que auxilia os países a: desenvolver e atualizar o respectivo NDVP para a introdução de vacinas contra a COVID-19; elaborar estratégias para a operacionalização e o monitoramento da(s) vacina(s) contra a COVID-19 no país; garantir que o plano e o financiamento relacionado estejam bem alinhados a outros planos nacionais de suporte à recuperação e resposta à COVID-19, e que a implementação esteja totalmente integrada nos mecanismos nacionais de governança.Este documento de orientação baseia-se em documentos de orientação já existentes sobre a introdução de novas vacinas, elaborados anteriormente pela OMS mediante consulta com especialistas no assunto, e é embasado por materiais recentes sobre vacinas contra a COVID-19, endossados pelo SAGE OM Tags: COVID-19, Vaccination, strategy, national action plan, National Vaccination Plan, NDVP, Source: https://iris.paho.org/bitstream/handle/1
	WHO supporting South African consortium to establish first COVID mRNA vaccine technology transfer hub World Health Organization WHO (2021) CC Open external link (7) Add to my MEDBOX 21 June 2021 Tags: skill transfer, mRNA, training hubs, Vaccine production, COVID-19, South Africa, Source: https://www.who.int/news/item/21-06-2021
	G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021 World Health Organization WHO; CEPI, GAVI, UNICEF (2021) C_WHO Open external link (20) Add to my MEDBOX 13 June 2021 Tags: vaccine, donations, COVID-19, G7, Access, covax, Source: https://www.who.int/news/item/13-06-2021
	Beschluss der STIKO zur 5. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung Vygen-Bonnet S, Koch J, Bogdan C, et al. (2021) C1 View PDF(15) Download (11) Add to my MEDBOX Epidemiologisches Bulletin 19 \| 2021 12.Mai 2021. Auf Basis der derzeit verfügbaren, allerdings noch begrenzten Evidenz und unter Berücksichtigung der gegenwärtigen pandemischen Lage empfiehlt die STIKO, Vaxzevria und COVID-19 Vaccine Janssen für Personen im Alter ≥60 Jahren zu verwenden. Der Einsatz von Vaxzevria für eine 1. oder 2. Impfstoffdosis und der COVID-19 Vaccine Janssen als einmalige Impfung unterhalb dieser Altersgrenze bleibt indes nach ärztlicher Aufklärung und bei individueller Risikoakzeptanz durch die impfwillige Person möglich Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson, Source: https://www.rki.de/DE/Content/Infekt/Epi

About MEDBOX

MEDBOX Video Series